Robert Williamson: Geneticist Who Mapped Disease Genes and Advanced Cell-Free DNA Research

Robert (Bob) Williamson was a geneticist who devoted his career to identifying genes associated with disease and improving the diagnosis and treatment of single-gene disorders. He was among the first scientists to use DNA markers to locate important human disease genes on chromosomes, mapping genes associated with cystic fibrosis (CF) and Duchenne muscular dystrophy (DMD).

This work contributed to the development of genetic tests for people with DMD-related gene mutations and expanded the genetic counselling available to affected families. Williamson also examined the ethical implications of population-wide genetic screening and the use of stem cells in research.

Bridging genetic research, medicine and public policy

Williamson was a shrewd politician who brought together people across the medical sector, from genetic researchers to clinicians, and worked closely with patient advocacy groups and the British government. After moving to Australia from the United Kingdom, he became interested in national science policy and medical and scientific ethics. He later advised several prime ministers and ministers.

All the ways cells can die – and why diversity matters

Early research on globin genes and blood diseases

Williamson was born in Cleveland, Ohio, and spent his childhood in New York City. When he was 16, his family moved to London. After completing undergraduate and postgraduate degrees in chemistry at University College London, he moved to the University of Glasgow in 1963 to become a lecturer in developmental biology.

At Glasgow, his research focused on the globin gene, which encodes the protein component of the oxygen-carrying molecule haemoglobin. His group showed that thalassaemias, a group of blood diseases, are often caused by deletions in the genes encoding alpha-globin and fetal haemoglobin. He then worked with colleagues to develop methods for prenatal diagnosis and carrier testing for these diseases.

Early discovery of cell-free DNA and the nucleosome ladder

Williamson’s research on haemoglobin synthesis in immature red blood cells led to studies of gene-expression regulation. While investigating unexpected free-floating DNA fragments that interfered with his experiments, he reported in 1970 that cell-free DNA was released from the nuclei of dead cells during development (R. Williamson, J. Mol. Biol. 51, 157–160; 1970).

In the same paper, he described the “nucleosome ladder”, a gel-electrophoresis pattern that reflects how DNA is organized within chromosomes. Williamson was particularly proud that these observations were recognized. His paper was published three years before the biological importance of nucleosomes was recognized and decades before cell-free DNA became a valuable diagnostic tool for cancer and other conditions.

What’s next for CRISPR: Companies editing epigenomes to treat diseases